Form D · Other Health Care
Navigantis, Inc.
Miami, FL · CIK 0001975338
Offering snapshot reported May 8, 2024 · SEC filing
- Reported sold
- $9.1M Offering amount: $9.1M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 29, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2024 | Initial | $9,100,000 | No comparison | 23 | SEC filing |
| May 5, 2023 | Initial | $800,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-512636
Source: Form D, filed May 8, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc Camprubi Artal | Executive |
| Mor Dayan | Director, Executive |
| Ivan Delvic | Director, Executive |
| Maurice Ferre | Director |
| Hyosig Kang | Executive |
| Jong Yun Won | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
801 Brickell Avenue Suite 1600
Miami, FL, 33131
Miami, FL, 33131